Contribution: Industrial Research Assistance Program – Contributions to Firms
Endoceutics inc.
$416,200.00
Development of a new oral formulation of DHEA
FY 2019-20 · 2019-08-05
Summary
Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
850923327
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-08-05 | 2019-20 | $649,840.00 |
| 4 | 2019-08-05 | 2019-20 | $649,840.00 |
| 5 | 2019-08-05 | 2019-20 | $649,840.00 |
| 6 | 2019-08-05 | 2019-20 | $416,200.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -610 days. The total amended value is -233,640 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de -610 jours. La valeur totale des modifications est de - 233 640 dollars.
Agreement End Date
2022-04-30
Agreement Number
932356
Agreement Start Date
2019-08-05
Agreement Title
Development of a new oral formulation of DHEA
Agreement Title (French)
Développement d'une nouvelle formulation orale de DHEA
Agreement Type
Contribution
Agreement Value
$416,200.00
Amendment Date
2022-09-08
Amendment Number
6
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women.
Description (French)
Développement d’une formulation orale de DHEA innovante pour le traitement des bouffées de chaleur chez la femme ménopausée.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Louis-Hébert
Federal Riding (French)
Louis-Hébert
Federal Riding Number
24044
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
850923327
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Endoceutics inc.
Recipient Postal Code
G1V 4M7
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2019-2020-Q2-932356
